Yasushi Otani

879 total citations
19 papers, 607 citations indexed

About

Yasushi Otani is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yasushi Otani has authored 19 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Yasushi Otani's work include COVID-19 Clinical Research Studies (3 papers), Lung Cancer Research Studies (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Yasushi Otani is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Lung Cancer Research Studies (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Yasushi Otani collaborates with scholars based in Japan and United States. Yasushi Otani's co-authors include Norihiro Suzuki, Yoshikazu Hasegawa, Kenji Yokota, Ryo Tanaka, Takashi Hirose, Shin-ichiro Inomata, Shigeaki Suzuki, Satoshi Fukushima, Makoto Matsui and Nobuhisa Ishikawa and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Yasushi Otani

18 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasushi Otani Japan 10 383 171 149 140 78 19 607
T Hotta Japan 12 224 0.6× 122 0.7× 143 1.0× 86 0.6× 116 1.5× 55 574
Heather M. Shaw United Kingdom 13 352 0.9× 132 0.8× 349 2.3× 39 0.3× 55 0.7× 34 725
Kyung Han Nam South Korea 14 428 1.1× 346 2.0× 227 1.5× 49 0.3× 44 0.6× 46 832
Eugene Tan United States 9 103 0.3× 83 0.5× 140 0.9× 109 0.8× 68 0.9× 20 413
Faezeh Khodadadi Iran 4 470 1.2× 135 0.8× 197 1.3× 33 0.2× 38 0.5× 6 749
Florentia Dimitriou Switzerland 16 665 1.7× 150 0.9× 250 1.7× 41 0.3× 87 1.1× 50 936
Margaret Ottaviano Italy 11 193 0.5× 71 0.4× 153 1.0× 98 0.7× 16 0.2× 62 450
Ali Küpelioğlu Türkiye 15 246 0.6× 86 0.5× 181 1.2× 28 0.2× 28 0.4× 39 578
Habib Sadeghirad Australia 7 509 1.3× 146 0.9× 238 1.6× 28 0.2× 40 0.5× 14 837
M. Bianchi Italy 12 191 0.5× 115 0.7× 330 2.2× 26 0.2× 20 0.3× 43 704

Countries citing papers authored by Yasushi Otani

Since Specialization
Citations

This map shows the geographic impact of Yasushi Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Otani more than expected).

Fields of papers citing papers by Yasushi Otani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Otani. The network helps show where Yasushi Otani may publish in the future.

Co-authorship network of co-authors of Yasushi Otani

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Otani. A scholar is included among the top collaborators of Yasushi Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Otani. Yasushi Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Otani, Yasushi, et al.. (2024). P1044 Mirikizumab Pharmacokinetics and Exposure-Response in a Phase 2 Study in Patients With Moderately to Severely Active Crohn’s Disease. Journal of Crohn s and Colitis. 18(Supplement_1). i1873–i1873. 2 indexed citations
2.
3.
Okauchi, Yukiyoshi, Tsutomu Nishida, Koichi Shinchi, et al.. (2021). Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19). Endocrine Journal. 68(7). 849–856. 8 indexed citations
4.
Kimura, Yoko, M. Mihara, K. Matsuta, et al.. (2021). Development of a small Beta-NMR system using Halbach Array permanent magnet. Hyperfine Interactions. 243(1). 1 indexed citations
5.
Nishida, Tsutomu, Hiromi Iwahashi, Yasushi Otani, et al.. (2020). Early clinical factors predicting the development of critical disease in Japanese patients with COVID‐19: A single‐center, retrospective, observational study. Journal of Medical Virology. 93(4). 2141–2148. 16 indexed citations
6.
Tanaka, Tatsurou, Masafumi Oda, Nao Wakasugi‐Sato, et al.. (2020). First Report of Sublingual Gland Ducts: Visualization by Dynamic MR Sialography and Its Clinical Application. Journal of Clinical Medicine. 9(11). 3676–3676. 2 indexed citations
7.
Yamamoto, Yuji, et al.. (2019). Anti-proteinase 3-positive Eosinophilic Granulomatosis with Polyangiitis Revealed by Cardiac Tamponade. Internal Medicine. 58(20). 3045–3050. 1 indexed citations
8.
Tamura, Hiromi, Yasushi Otani, Takashi Iwazawa, et al.. (2018). Extracranial meningiomas concurrently found in the lung and vertebral bone: a case report. Journal of Medical Case Reports. 12(1). 279–279. 1 indexed citations
9.
Suzuki, Shigeaki, Nobuhisa Ishikawa, Fumie Konoeda, et al.. (2017). Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology. 89(11). 1127–1134. 296 indexed citations
10.
Takimoto, Takayuki, Takashi Kijima, Yasushi Otani, et al.. (2013). Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity. Clinical Lung Cancer. 14(5). 502–507. 49 indexed citations
11.
Minami, Toshiyuki, Takashi Kijima, Hisashi Arase, et al.. (2013). Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis. Scientific Reports. 3(1). 2669–2669. 24 indexed citations
12.
Hirata, Haruhiko, Hiroshi Kida, Masanori Matsumoto, et al.. (2013). Drug-induced Thrombotic Thrombocytopenic Purpura Successfully Treated with Recombinant Human Soluble Thrombomodulin. Internal Medicine. 52(10). 1111–1114. 11 indexed citations
13.
Minami, Toshiyuki, Takashi Kijima, Yasushi Otani, et al.. (2012). HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter–Mediated Chemoresistance in Small Cell Lung Cancer. Molecular Cancer Therapeutics. 11(4). 830–841. 24 indexed citations
14.
Otani, Yasushi, Takashi Kijima, Shinya Oishi, et al.. (2012). Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016. FEBS Letters. 586(20). 3639–3644. 23 indexed citations
15.
Arimitsu, Junsuke, Keisuke Hagihara, Y. KISHIDA, et al.. (2011). The Effect of Saffron in Patients with Autoimmune Diseases. Kampo Medicine. 62(4). 548–555. 1 indexed citations
16.
Kijima, Takashi, Shinpei Nonen, Yasushi Otani, et al.. (2011). Safe and Successful Treatment With Erlotinib After Gefitinib-Induced Hepatotoxicity: Difference in Metabolism As a Possible Mechanism. Journal of Clinical Oncology. 29(19). e588–e590. 46 indexed citations
17.
Kijima, Takashi, Yasushi Otani, Masahide Mori, et al.. (2010). Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung Cancer. Cancer Research. 70(20). 8025–8035. 59 indexed citations
18.
Otani, Yasushi, Kazuo Nishimura, Natsuki Takaha, et al.. (2004). Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment. Metabolism. 54(1). 55–59. 39 indexed citations
19.
Otani, Yasushi, et al.. (1996). Preoperative Intra-arterial Infusion Chemotherapy for Invasive Thymoma: A Case Report. Japanese Journal of Clinical Oncology. 26(6). 476–479. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Hotta Breakdown of academic impact, for papers by Heather M. Shaw Breakdown of academic impact, for papers by Kyung Han Nam Breakdown of academic impact, for papers by Eugene Tan Breakdown of academic impact, for papers by Faezeh Khodadadi Breakdown of academic impact, for papers by Florentia Dimitriou Breakdown of academic impact, for papers by Margaret Ottaviano Breakdown of academic impact, for papers by Ali Küpelioğlu Breakdown of academic impact, for papers by Habib Sadeghirad Breakdown of academic impact, for papers by M. Bianchi
Rankless by CCL
2026